Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Neha J Pagidipati"'
Autor:
Apurva Khedagi, Cara Hoke, Michelle Kelsey, Andrea Coviello, W. Schuyler Jones, Larry R. Jackson, II, Manesh R Patel, Rob W. McGarrah, Neha J Pagidipati, Nishant P. Shah
Publikováno v:
American Journal of Preventive Cardiology, Vol 13, Iss , Pp 100477- (2023)
Cardiovascular disease remains one of the most prominent global health problems and has been demonstrated to disproportionally affect certain communities. Despite an increasing collective effort to improve health inequalities, a multitude of disparit
Externí odkaz:
https://doaj.org/article/0c56833b0aa04ebf94cf6b81e37f08c5
Autor:
Nathan A Bihlmeyer, Lydia Coulter Kwee, Clary B Clish, Amy Anderson Deik, Robert E Gerszten, Neha J Pagidipati, Blandine Laferrère, Laura P Svetkey, Christopher B Newgard, William E Kraus, Svati H Shah
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0240764 (2021)
Obesity is an epidemic internationally. While weight loss interventions are efficacious, they are compounded by heterogeneity with regards to clinically relevant metabolic responses. Thus, we sought to identify metabolic biomarkers that are associate
Externí odkaz:
https://doaj.org/article/411ee50441d3462a8896a1a30b7353c8
Autor:
Elizabeth A. Kobe, Aarti Thakkar, Sarina Matai, Esra Akkaya, Neha J. Pagidipati, Robert W. McGarrah, Gerald S. Bloomfield, Nishant P. Shah
Publikováno v:
American Journal of Preventive Cardiology, Vol 20, Iss , Pp 100888- (2024)
Effective antiretroviral therapy (ART) is now nearly ubiquitous. However, the survival benefits conferred with ART contribute to an aging human immunodeficiency virus (HIV) population and increased risk of chronic diseases, like atherosclerotic cardi
Externí odkaz:
https://doaj.org/article/abd1b9361a1a4324bfd0ab263ef5ebed
Autor:
Nishant P. Shah, Hillary Mulder, Elizabeth Lydon, Karen Chiswell, Xingdi Hu, Zachary Lampron, Lauren Cohen, Manesh R. Patel, Susan Taubes, Wenliang Song, Suresh R. Mulukutla, Anum Saeed, Daniel P. Morin, Steven M. Bradley, Adrian F. Hernandez, Neha J. Pagidipati
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 21 (2024)
Background Lipoprotein (a) is an independent risk factor for atherosclerotic cardiovascular disease. However, lipoprotein (a) testing remains variable and it is unclear what factors influence testing and if testing changes clinical management. Method
Externí odkaz:
https://doaj.org/article/ed019922204943ada82ff09598bb40f4
Autor:
Neha J Pagidipati, Mark D Huffman, Panniyammakal Jeemon, Rajeev Gupta, Prakash Negi, Thannikot M Jaison, Satyavan Sharma, Nakul Sinha, Padinhare Mohanan, B G Muralidhara, Sasidharan Bijulal, Sivasubramonian Sivasankaran, Vijay K Puri, Jacob Jose, K Srinath Reddy, Dorairaj Prabhakaran
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e62061 (2013)
BACKGROUND:Studies from high-income countries have shown that women receive less aggressive diagnostics and treatment than men in acute coronary syndromes (ACS), though their short-term mortality does not appear to differ from men. Data on gender dif
Externí odkaz:
https://doaj.org/article/167e06370ca9432283ade390e9164a04
Autor:
Adam J. Nelson, Maddalena Ardissino, Kevin Haynes, Sonali Shambhu, Zubin J. Eapen, Darren K. McGuire, Anthony Carnicelli, Renato D. Lopes, Jennifer B. Green, Emily C. O’Brien, Neha J. Pagidipati, Christopher B. Granger
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 2 (2021)
Background Evidence‐based therapies are generally underused for cardiovascular risk reduction; however, less is known about contemporary patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease. Methods and Results Pharmacy
Externí odkaz:
https://doaj.org/article/340cb20ddead4940ba2ab946e973e3e5
Autor:
Adam J, Nelson, Josephine L, Harrington, Ahmed A, Kolkailah, Neha J, Pagidipati, Darren K, McGuire
Publikováno v:
Heart Failure Clinics. 18:597-607
Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) improve the risk for heart and kidney failure. However, their effects on major atherosclerotic cardiovascular events (MACE) are less clear. Although outcomes trials of drugs for diabetes were not po
Autor:
Jelani K. Grant, Sarah Snow, Michelle Kelsey, Jennifer Rymer, Anna E. Schaffer, Manesh R. Patel, Robert W. McGarrah, Neha J. Pagidipati, Nishant P. Shah
Publikováno v:
Current Cardiology Reports. 24:1373-1385
Autor:
Elizabeth Zhao, Stephanie N. Giamberardino, Neha J. Pagidipati, Deepak Voora, Geoffrey S. Ginsburg, Udo Hoffmann, Júlia Karády, Maros Ferencik, Pamela S. Douglas, Borek Foldyna, Svati H. Shah
Publikováno v:
Journal of the American Heart Association.
Background The interplay between branched‐chain amino acid (BCAA) metabolism, an important pathway in adiposity and cardiometabolic disease, and visceral adipose depots such as hepatic steatosis (HS) and epicardial adipose tissue is unknown. We lev
Autor:
Angela Lowenstern, Karen P. Alexander, Neha J. Pagidipati, C. Larry Hill, Patricia A. Pellikka, Lawton S. Cooper, Brooke Alhanti, Udo Hoffmann, Daniel B. Mark, Pamela S. Douglas
Publikováno v:
Circ Cardiovasc Qual Outcomes
Background: Patients evaluated for coronary artery disease have a range of symptoms and underlying risk. The relationships between patient-described symptoms, clinician conclusions, and subsequent clinical management and outcomes remain incompletely